Bill Martin, PhD
Bill Martin is the chief scientific officer and head of research and development at BlackThorn Therapeutics, a company focused on creating novel targeted medicines for neurodevelopmental disorders. Prior to joining BlackThorn, Martin worked at Theravance Biopharma, where his responsibilities ranged from drug discovery and development, to research portfolio planning and business development. He is the chair of SfN’s Government and Public Affairs Committee. Martin graduated from Swarthmore College and earned his PhD from Brown University. He conducted postdoctoral research at the Keck Center for Integrative Neuroscience at the University of California, San Francisco.